DIFFUSE ASTROCYTOMA, IDH-MUTANT

Clinical trials for DIFFUSE ASTROCYTOMA, IDH-MUTANT explained in plain language.

Never miss a new study

Get alerted when new DIFFUSE ASTROCYTOMA, IDH-MUTANT trials appear

Sign up with your email to follow new studies for DIFFUSE ASTROCYTOMA, IDH-MUTANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New pill tested to fight aggressive brain cancers

Disease control Recruiting now

This study is testing a new oral medication called NEO212 for adults with specific aggressive brain tumors (like glioblastoma) or brain metastases from other cancers. The main goals are to find a safe and effective dose, see how the body processes the drug, and check if it can he…

Matched conditions: DIFFUSE ASTROCYTOMA, IDH-MUTANT

Phase: PHASE1, PHASE2 • Sponsor: Neonc Technologies, Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

DIFFUSE ASTROCYTOMA, IDH-MUTANT

Get alerted when new DIFFUSE ASTROCYTOMA, IDH-MUTANT trials appear

New pill tested to fight aggressive brain cancers